Inhibition of human liver microsomal (S)-nicotine oxidation by (-)-menthol and analogues

Chemical Research in Toxicology

Volumn 16, Issue 8, 2003, Pages 988-993

  MacDougall, James M ^a   Fandrick, Keith ^a   Zhang, Xiaodong ^a   Serafin, Scott V ^b   Cashman, John R ^a  

^a HUMAN BIOMOLECULAR RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; FLAVORING AGENT; MENTHOL; NICOTINE; TOOTHPASTE;

ANIMAL TISSUE; ARTICLE; CANCER RISK; CAUCASIAN; CIGARETTE SMOKING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME INHIBITION; ETHNOLOGY; FOOD; HUMAN; HUMAN TISSUE; LIVER MICROSOME; LUNG CANCER; MALE; MOUTHWASH; NEGRO; NONHUMAN; OXIDATION; RAT;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; COTININE; COUMARINS; CYTOCHROME P-450 ENZYME SYSTEM; HAPLORHINI; HUMANS; MENTHOL; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES; NICOTINE; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; SMOKING; STEREOISOMERISM; STEROID HYDROXYLASES;

ANIMALIA; PIERINAE;

EID: 0042863398     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx0340551     Document Type: Article

References (32)

1. Thorup, I., Wurtzen, G., Carstensen, J., and Olsen, P. (1983) Short-term toxicity study in rats with pulegone and menthol. Toxicol. Lett. 19, 207-210.
2. Macht, D. I. (1939) Comparative pharmacology of menthol and its isomers. Arch. Int. Pharmacodyn. 63, 43-58.
3. Gelal, A., Jacob, P., III, Yu, L., and Benowitz, N. L. (1999) Disposition kinetics and effects of menthol. Clin. Pharmacol. Ther. 66, 128-135.
4. Opdyke, D. L. (1976) Monographs on fragrance raw materials. Food Cosmet. Toxicol. 14, 443-481.
5. Harris, R. E., Zang, E. A., Anderson, J. I., and Wynder, E. L. (1993) Race and sex differences in lung cancer risk associated with cigarette smoking. Int. J. Epidemiol. 22, 592-599.
6. Wagenknecht, L. E., Cutter, G. R., Haley, N. J., Sidney, S., Manolio, T. A., Hughes, G. N., and Jacobs, D. R. (1990) Racial differences in serum cotinine levels among smokers in the coronary artery risk development in (Young) adults study. Am. J. Public Health 80, 1053-1056.
7. Sidney, S., Tekawa, I. S., Friedman, G. D., Sadler, M. C., and Taskin: D. P. (1995) Mentholated cigarette use and lung cancer. Arch. Intern. Med. 155, 727-732.
8. Cooper, H., and Simmons, B. E. (1985) Cigarette smoking and ill health among black Americans. N. Y. State J. Med. 85, 344-349.
9. U.S. Department of Health and Human Services (1987) The Impact of Cigarette Smoking on Minority Populations. Committee on Smoking and Health, Public Health Service Center for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health, U.S. Government Printing Office, Washingtonk, DC.
10. Clark, P. I., Gautam, S., and Gerson, L. W. (1996) Effect of menthol cigarettes on biochemical markers of smoke exposure among black and white smokers. CHEST 110, 1194-1198.
11. Bell, G. D., Dutka, D. P., Henry, D. A., and Langman, M. J. S. (1987) Glucuronidation of l-menthol in man: the effects of prior treatment with cimetidine and phenobarbitone (Abstract). Br. J. Clin. Pharmacol. 12, 274P.
12. Quick, A. J. (1928) Quantitative studies of l-menthol oxidation: metabolism of conjugated glycuronic acids. J. Biol. Chem. 80, 535-541.
13. Madyastha, K. M., and Srivatsan, V. (1988) Studies on the metabolism of l-menthol in rats. Drug Metab. Dispos. 16, 765-772.
14. 3H-l-menthol in the rat. Drug Metab. Dispos. 22, 616-624.
15. Ishidate, M., Jr., Sofuni, T., Yoshikawa, K., Hayashi, M., Nohmi, T., and Sawada, M. (1984) Primary mutagenicity screen of food additives currently used in Japan. Food Chem. Toxicol. 22, 623-636.
16. Ohta, T., Watanabe, M., Watanabe, K., Shirasu, Y., and Kada, T. (1986) Inhibitory effects of flavorings on mutagenesis induced by chemicals in bacteria. Food Chem. Toxicol. 24, 51-54.
17. Kobayashi, D., Matsuzawa, T., Sugibayashi, K., Morimoto, Y., and Kimura, M. (1994) Analysis of the combined effects of l-menthol and ethanol as skin permeation enhances based on a two-layer skin model. Pharm. Res. 11, 96-103.
18. Miller, G. E., Jarvik, M. E., Caskey, N. H., Segerstrom, S. C., Rosenblatt, M. R., and McCarthy, W. J. (1994) Cigarette mentholation increases smokers' exhaled carbon monoxide levels. Exp. Clin. Psychopharmacol. 2, 154-160.
19. Schmeltz, I., and Schlotzhauer, W. S. (1968) Benz[a]pyrene, phenols and products from pyrolysis of the cigarette additive (D,L)-menthol. Nature 219, 370-371.
20. Cashman, J. R., Park, S. B., Yang, Z. C., Wrighton, S., Jacob, P., III, and Benowitz, N. L. (1992) Metabolism of nicotine by human liver microsomes: stereoselective formation of trans-nicotine N′-oxide. Chem. Res. Toxicol. 5, 639-646.
21. Greenlee, W. F., and Poland, A. (1978) An improved assay of 7-ethoxycoumarin O-deethylase activity: induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p- dioxin J. Pharm. Exp. Ther. 205, 596-605.
22. Buters, J. T. M., Korzekwa, K. R., Kunze, K. L., Omata, Y., Hardwick, J. P., and Gonzales, F. J. (1994) cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus Drug Metab. Dispos. 22, 688-692.
23. Berkman, C. E., Park, S. B., Wrighton, S. A., and Cashman, J. R. (1995) In vitro-in vivo correlations of human (S)-nicotine metabolism. Biochem. Pharmacol. 50, 565-570.
24. Perez-Stable, E. J., Herrera, B., Jacob, P., III, and Benowitz, N. L. (1998) Nicotine metabolism and intake in black and white smokers. JAMA 200, 152-156.
25. Benowitz, N. L., Perez-Stable, E. J., Herrera, B., and Jacob, P., III (2002) Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans. J. Natl. Cancer Inst. 94, 108-115.
26. Coultas, D. B., Gong, H., Jr., Grad, R., Handler, A., McCurdy, S. A., Player, R., Rhoades, E. R., Samet, J. M., Thomas, A., and Westley, M. (1994) Respiratory diseases in minorities of the United States. Am. J. Respir. Crit. Case Med. 149, S93-131.
27. From the Center of Disease Control and Prevention, Cigarette smoking among adults-United States, 1995. (1997) MMWR Morb. Mortal. Wkly. Rep. 46, 1217-1220.
28. Jarvik, M. E., Tashkin, D. P., Caskey, N. H., McCarthy, W. J., and Rosenblatt, M. R. (1994) Mentholated cigarettes decrease puff volume of smoke and increases carbon monooxide absorption. Physiol. Behav. 56, 563-570.
29. McCarthy, W. J., Caskey, N. H., Jarvik, M. E., Gross, T. M., Rosenblatt, M. R., and Carpenter, C. (1995) Menthol vs non-menthol cigarettes: effects on smoking behavior. Am. J. Public Health 85, 67-72.
30. Sellers, E. M., Zeman, M. V., Kaplan, H. L. and Tyndale, R. F. (2000) Inhibition of cytochrome P450 2A6 (CYP2A6) decreases smoking and activation of the procarcinogen 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK). Clin. Pharmacol. Ther. 67, 113-118.
31. Recent Advances in Tobacco Science (1993) A history of mentholated cigarettes. "This spud's for you. Proceedings of a Symposium presented at the 47th Meeting of the Tobacco Chemists' Research Conference. (Reid, J. R., Ed.) pp 71-84.
32. Yamazaki, II., Inui, Y, Yun, C. H., Guengerich, F. P., and Shimada, T. (1992) Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosoamines in human liver microsomes. Carcinogenesis 13, 1789-1794.